A study of nerve cell health in people with mood disorders
Part of Mental health clinical trials.
This trial looks at a protein in the blood (neurofilament light chain) that may show how mood disorders like major depression or bipolar disorder affect the brain over time. It compares people with mood disorders to healthy individuals to find patterns linked to symptom severity and thinking problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 50 years old
- You have been diagnosed with major depression or bipolar disorder (manic episode)
- You do not have any major medical or brain diseases
- You have not had a traumatic brain injury or major fracture
- You do not have a history of alcohol or drug use disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study evaluates people with mood disorders (like depression or bipolar disorder), anxiety disorders, or people without these conditions to better understand how these conditions develop and affect the brain. Researchers will ask questions and may do other assessments to learn more.
This study uses a mobile app and brain scans to understand day-to-day mood changes in people with depression or bipolar disorder. It may help doctors learn how to better predict and treat these conditions.
This trial creates a flexible platform to test new treatments for mood disorders like bipolar disorder and depression. It also includes healthy volunteers as a comparison group.
This study looks at neurofilament light (a brain/nerve injury marker) and how it relates to thinking and memory problems in people with certain psychiatric conditions. It may help researchers understand brain changes and cognitive impairment, which could guide better diagnosis in the future.
This study looks at how social factors and blood markers relate to psychiatric symptoms in people with brain diseases or mental disorders. It aims to find new ways to understand and diagnose these conditions.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
Hear when a new Mood Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.